Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Philip Reed Larsen, M.D.

Concepts

This page shows the publications Philip Larsen has written about Cyclic AMP.
Connection Strength

0.400
  1. Characterization of the 5'-flanking and 5'-untranslated regions of the cyclic adenosine 3',5'-monophosphate-responsive human type 2 iodothyronine deiodinase gene. Endocrinology. 2000 Jan; 141(1):229-37.
    View in: PubMed
    Score: 0.146
  2. Triiodothyronine causes rapid reversal of alpha 1/cyclic adenosine monophosphate synergism on brown adipocyte respiration and type II deiodinase activity. Metabolism. 1991 Dec; 40(12):1327-32.
    View in: PubMed
    Score: 0.083
  3. Multihormonal regulation of the human, rat, and bovine growth hormone promoters: differential effects of 3',5'-cyclic adenosine monophosphate, thyroid hormone, and glucocorticoids. Mol Endocrinol. 1988 Sep; 2(9):792-8.
    View in: PubMed
    Score: 0.067
  4. Chronic cardiac-specific thyrotoxicosis increases myocardial beta-adrenergic responsiveness. Mol Endocrinol. 2004 Jul; 18(7):1840-9.
    View in: PubMed
    Score: 0.049
  5. Pituitary cells respond to thyroid hormone by discrete, gene-specific pathways. Endocrinology. 1995 Apr; 136(4):1488-94.
    View in: PubMed
    Score: 0.026
  6. Alpha 1- and beta-adrenergic agents cause synergistic stimulation of the iodothyronine deiodinase in rat brown adipocytes. Endocrinology. 1989 Nov; 125(5):2502-9.
    View in: PubMed
    Score: 0.018
  7. The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest. 2001 Nov; 108(9):1379-85.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.